Yuk-Ming Dennis Lo

This inventor holds 81 USPTO granted patents and 79 published patent applications, plus 13 CIPO patents and 53 EPO patents, primarily in Nucleic Acid Analysis (CPC class C12Q). Top assignees: The Chinese University of Hong Kong, Grail, Inc., Centre for Novostics. Active years: 2001-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuk-Ming Dennis Lo. Retrieved from https://idiyas.com/inventor/yuk-ming-dennis-lo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 81 (Patent Applications = 79)

% Patents Active = 93.8

CIPO Patents = 13 (Patent Applications = 38)

EPO Patents = 53 (Patent Applications = 91)

Average Co-Inventor Count = 4.3

ph-index = 13

Forward Citations = 1,396(Granted Patents)

Forward Citations (Not Self Cited) = 1,151(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Homantin, Kowloon, CN (2015)
Kowloon, CN (2001 - 2024)
Hong Kong, CN (2007 - 2024)
Homantin, CN (2015 - 2024)

Company Filing History:

74 out of 503

The Chinese University of Hong Kong

Isis Innovation Limited

patents

where one patent can have more than one assignee

Years Active: 2001-2026

Loading Chart...

Areas of Expertise:

Nucleic Acid Analysis

Methylation Patterns

Cancer Detection

Cell-Free DNA

Genomic Sequencing

Fetal Chromosomal Abnormalities

Urinary DNA

Tumor Detection

Maternal Plasma

DNA Fragmentation

Viral Nucleic Acids

Diagnostic Methods

81 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12760362 - Single-molecule sequencing of plasma DNA (2026-10-13),

2. 12747466 - Analysis of nucleic acids associated with extracellular vesicles in pregnant females (2026-09-29),

3. 12742208 - FRAGMENTATION FOR MEASURING METHYLATION AND DISEASE (2026-09-22),

4. 12692553 - Methods and systems for tumor detection (2026-07-28),

5. 12595511 - Methods using characteristics of urinary and other DNA (2026-04-07),

6. 12518854 - Non-invasive detection of tissue abnormality using methylation (2026-01-06),

7. 12460269 - Methods for analyzing viral nucleic acid (2025-11-04),

8. 12416049 - Methylation pattern analysis of haplotypes in tissues in a DNA mixture (2025-09-16),

9. 12258634 - Fragmentation for measuring methylation and disease (2025-03-25),

10. 12247259 - Using nucleic acid size range for noninvasive cancer detection (2025-03-11),

11. 12234515 - Enhancement of cancer screening using cell-free viral nucleic acids (2025-02-25),

12. 12227804 - Determining a nucleic acid sequence imbalance associated with cancer using multiple markers (2025-02-18),

13. 12190998 - Combined size- and count-based analysis of maternal plasma for detection of fetal subchromosomal aberrations (2025-01-07),

14. 12180549 - Diagnosing fetal chromosomal aneuploidy using genomic sequencing (2024-12-31),

15. 12139750 - Molecular analyses using long cell-free fragments in pregnancy (2024-11-12),

Title: The Innovative Journey of Yuk-Ming Dennis Lo

Introduction: Yuk-Ming Dennis Lo is a pioneering inventor hailing from Homantin, China. His groundbreaking work in the field of innovations has significantly impacted the world of science and technology.

Latest Patents: Yuk-Ming Dennis Lo holds several patents in the field of biotechnology and medical diagnostics, focusing on non-invasive methods for early disease detection.

Career Highlights: With a distinguished career spanning several decades, Yuk-Ming Dennis Lo has been at the forefront of cutting-edge research, particularly in the development of liquid biopsy techniques for cancer detection.

Collaborations: Throughout his career, Yuk-Ming Dennis Lo has collaborated with leading research institutions, universities, and biotech companies to further advance the field of molecular diagnostics.

Conclusion: Yuk-Ming Dennis Lo's relentless pursuit of innovation and his commitment to improving healthcare through technology make him a true visionary in the world of inventions.

Profile summary based on public USPTO records.